Holdings of venBio Partners LLC
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 5 in 1 countries
- Top ten
- 100.0 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Alumis Inc | 4,528,408 | 99.8M $ | |
| 2 | ALX Oncology Holdings Inc | 12,884,638 | 25.8M $ | |
| 3 | Harmony Biosciences Holdings Inc | 489,194 | 13.7M $ | |
| 4 | Lyell Immunopharma Inc | 337,697 | 6.8M $ | |
| 5 | Artiva Biotherapeutics Inc | 531,337 | 3.4M $ |
Sector breakdown
- Unattributed 100.0 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- United States 100.0 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 5 | 149.5M $ | 100.00 % |
Cite this page
Titelia. "Holdings of venBio Partners LLC". https://titelia.com/en/funds/US13F1776382